Radiopharmaceutical development leader brings over two decades of global oncology clinical experience to Lila Bio, including senior roles at RayzeBio and Abdera Therapeutics.
We are thrilled to welcome Joerg to Oak Hill Bio at such an exciting time for our company,” said Josh Distler, Chief Executive Officer of Oak Hill Bio. “Joerg was an integral member of the team that ...
Financing will advance a potential once-daily oral treatment designed to restore blood vessel stability in HHT, a serious ...
TRex Bio IPO set at $14-$16 per share targeting $133.3 million on Nasdaq, with Eli Lilly indicating interest in a 19.9% stake ...
PHILIPSBURG--St. Maarten Academy recorded 318 Grade One results in the 2026 Caribbean Secondary Education Certificate (CSEC) ...
In late May 2025, Syracuse football offered a scholarship to 2029 four-star defensive lineman/edge rusher Kymani Nicholas.
The Council for the Indian School Certificate Examinations (CISCE) is expected to release the ICSE Class 10 Date Sheet 2027 ...
Results from the Phase 3 part of AMETHYST are expected in the first half of 2027; in January 2026 the FDA granted ...
Seoul Bio Hub opened the second NextBio Leaders Academy, a 10-week executive program for about 30 leaders of resident biotech ...
Over the past month, the Class of 2030 has been settling into new routines. From a record-breaking applicant pool, the Class of 2030 broke records again as one of Bowdoin’s largest first-year classes ...
The Class of 2030 has arrived. The University of Chicago welcomed its newest students to campus last week, each of them ready ...
Plastics that mend their own cracks have long been a dream of materials science, but most self-healing polymers still depend ...